![Surendra Singh](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Surendra Singh
Corporate Officer/Principal chez INHIBIKASE THERAPEUTICS, INC.
Profil
Surendra Singh is currently the Head-Chemistry & Manufacturing & Controls at Inhibikase Therapeutics, Inc. He previously worked as the Director-Chemical Process Research at Sumitomo Pharma America, Inc. from 2001 to 2011.
Dr. Singh obtained his doctorate degree from the Indian Institute of Technology Madras in 1991.
Postes actifs de Surendra Singh
Sociétés | Poste | Début |
---|---|---|
INHIBIKASE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/08/2014 |
Anciens postes connus de Surendra Singh
Sociétés | Poste | Fin |
---|---|---|
Sumitomo Pharma America, Inc.
![]() Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Corporate Officer/Principal | 01/01/2011 |
Formation de Surendra Singh
Indian Institute of Technology Madras | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
INHIBIKASE THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Sumitomo Pharma America, Inc.
![]() Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |